Publication: Comparison between optical microscopy and the Sysmex XN-3000 for schistocyte determination in patients suspected of having schistocytosis
Issued Date
2020-03-01
Resource Type
ISSN
23988835
DOI
Other identifier(s)
2-s2.0-85083513374
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Health Science Reports. Vol.3, No.1 (2020)
Suggested Citation
Chattree Hantaweepant, Natthaporn Sasijareonrat, Boonyanuch Chutvanichkul, Khemajira Karaketklang, Yingyong Chinthammitr Comparison between optical microscopy and the Sysmex XN-3000 for schistocyte determination in patients suspected of having schistocytosis. Health Science Reports. Vol.3, No.1 (2020). doi:10.1002/hsr2.138 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54621
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Comparison between optical microscopy and the Sysmex XN-3000 for schistocyte determination in patients suspected of having schistocytosis
Other Contributor(s)
Abstract
© 2019 The Authors. Health Science Reports published by Wiley Periodicals, Inc. Background and aims: Diagnosis of thrombotic microangiopathy (TMA) relies on microscopic schistocyte determination by an experienced microscopist. In addition, schistocytes can be found in non-TMA–related disorders such as thalassaemia. We aimed to compare the accuracy of the automated haematology analyser Sysmex XN-3000 for schistocyte detection, to that of the microscopy approach, in patients suspected of having schistocytosis. Methods: Consecutive blood samples were collected between April 2016 and March 2017 at Siriraj Hospital, Mahidol University, Bangkok, Thailand. Specimens were collected from adults with suspected TMA or with thalassaemia trait and/or disease. All blood samples were examined by both microscopy and the analyser. Samples were considered to be positive for schistocytes (ie, schistocytosis) if they had a schistocyte count ≥1% by microscopy. The analyser's ability to determine schistocytosis was assessed by receiver operating characteristic (ROC) curve. Sensitivity, specificity, positive (PPV), and negative predictive value (NPV) of an appropriate cut-off point were calculated, with manual microscopy as the standard. Quantitative agreement in schistocyte counts between the two approaches was assessed using 95% limits of agreement, Bland-Altman plots, intraclass correlation coefficient, and concordance correlation coefficient. Results: Ninety-seven blood samples (62 suspected TMA and 35 thalassaemia) were collected. ROC curve analysis of the analyser for determining schistocytosis showed an area under the curve of 0.803 (95% confidence interval, 0.689-0.917, P < 0.001). A cut-off point of 0.6% yielded 86.1% sensitivity, 77.8% specificity, 94.4% PPV, and 56.0% NPV. The automated schistocyte count did not quantitatively agree with schistocyte counts by microscopy, neither in all blood specimens (mean of difference: −1.09; 95% limits of agreement, −11.9 to 9.7) nor in the subgroups (TMA, −0.88; 95% limits of agreement, −6.60 to 4.84; thalassaemia, −2.4; 95% limits of agreement, −14.10 to 9.30). The differences in the estimation of fragmented red blood cells between the methods tended to increase at higher schistocyte counts. Conclusion: Sysmex XN-3000 can be used for qualitative measurement of schistocytosis, but should not be used as a quantitative tool for schistocyte counting. Improvements are needed before this analyser's schistocyte detection feature can be recommended for use in clinical practice.